
Kelun-Biotech's TROP2 ADC Sacituzumab tirumotecan (sac-TMT) Approved For Marketing By NMPA Of China For 2L+ Advanced or Metastatic TNBC
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Domestic services
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
State grid Shizuishan power supply Company
Vantage Prime Trading Limited
Busan Tourism Organization